Genes and Development

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


GENES & DEVELOPMENT 3:1647-1656, 1989
ISSN 0890-9369
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espeseth, A S
Right arrow Articles by Linney, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espeseth, A S
Right arrow Articles by Linney, E
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Research Papers

Retinoic acid receptor expression vector inhibits differentiation of F9 embryonal carcinoma cells.

A S Espeseth, S P Murphy, and E Linney

Department of Microbiology and Immunology, Duke University Medical Center, North Carolina 27710.

Abstract

Expression vectors have been constructed for a region of the human retinoic acid receptor-alpha (hRAR-alpha) and transferred into F9 embryonal carcinoma (EC) cells. When the vectors are overexpressed in F9 cells, clones can be selected for resistance to retinoic acid-induced differentiation. This effect is obtained even when the hRAR-alpha region is expressed as a beta-galactosidase fusion protein. Using the beta-galactosidase component of the fusion protein as a marker, overexpression of the fusion protein has been correlated with the retinoic acid-resistance effect. The clones resistant to retinoic acid no longer exhibit the normal retinoic acid induction of endo B cytokeratin, laminin B-1, and tissue plasminogen activator mRNAs observed with normal F9 cells. Retinoic acid induction of type IV alpha-1 collagen and Hox-1.3 RNAs is observed with these clones. When transfected with a thyroid receptor DNA-binding sequence (TRE)/thymidine kinase promoter/luciferase construct, the retinoic acid-resistant clones do not yield the same retinoic acid-induced level of luciferase obtained with F9 cells. It is hypothesized that the RAR vectors are interfering with endogenous RAR(s) in a dominant-negative manner to inhibit retinoic acid-induced differentiation of F9 EC cells.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
Y Kishimoto, K. Lee, L Zon, M Hammerschmidt, and S Schulte-Merker
The molecular nature of zebrafish swirl: BMP2 function is essential during early dorsoventral patterning
Development, January 11, 1997; 124(22): 4457 - 4466.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
B. Aneskievich and E Fuchs
The A/B domain of truncated retinoic acid receptors can block differentiation and promote features of malignancy
J. Cell Sci., January 1, 1995; 108(1): 195 - 205.
[Abstract] [PDF]


Home page
DevelopmentHome page
M Wagner, B Han, and T. Jessell
Regional differences in retinoid release from embryonic neural tissue detected by an in vitro reporter assay
Development, January 9, 1992; 116(1): 55 - 66.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Genome Res. Learn. Mem.
Protein Science RNA Genes Dev.